Search
- May 25, 2021
- 6 min
NeuroRx merges with Big Rock Partners and begins trading on Nasdaq under the stock symbol NRXP
NRx expects to seek Emergency Use Authorization from the FDA to treat critical Covid-19 in patients suffering respiratory failure.
- May 22, 2021
- 2 min
Sensyne Health and Phesi to collaborate on clinical development with a US-based strategic partner
The development work involves the analysis of anonymized and real world patient data to optimise the design of a clinical trial
- May 18, 2021
- 6 min
Hummingbird Bioscience closes on $125 million for clinical trials and precision therapeutics
Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies to improve treatment outcomes
- May 2, 2021
- 5 min
Unity Biotechnology presents preclinical data for Diabetic Retinopathy Eye Diseases
we aim to provide an effective therapeutic option that selectively eliminates diseased and leaky cells within blood vessels...
- Apr 26, 2021
- 2 min
Kintor Pharmaceutical starts US Phase III trials for the treatment of Covid-19 symptoms
Initiation of this phase III study of proxalutamide for COVID-19 symptoms is a key milestone in the development of therapies